Effects of 25-hydroxycholesterol, cholesterol, and isoprenoid derivatives on the G1 progression in Swiss 3T3 cells.
The effect of inhibition of 3-Hydroxy-3-methylglutaryl Coenzyme A reductase (HMG CoA reductase) on cell cycle progression in proliferating 3T3 cells was studied. It was found that short transient exposures to the HMG CoA reductase inhibitor 25-hydroxycholesterol temporarily blocked the cell cycle traverse in the postmitotic half of G1 (G1pm), whereas cells in the subsequent cell cycle phases were unaffected. The kinetics of the cell cycle delay, induced by 25-hydroxycholesterol, resembled the kinetics of the delay induced by serum depletion, which also inhibited the activity of HMG CoA reductase. In contrast to the case of serum depletion, platelet derived growth factor (PDGF), which efficiently prevented the decrease of HMG CoA reductase in serum-free medium, was not capable of preventing the growth inhibitory effect following treatment by 25-hydroxycholesterol. However, cholesterol and two isoprenoids, dolichol and coenzyme Q, were effective in this respect. In addition, dolichol counteracted the cell cycle delay following short periods of serum starvation.
D002453:Cell Cycle / Q000187:drug effects; D002460:Cell Line; D002784:Cholesterol / Q000494:pharmacology*; D004224:Diterpenes / Q000494:pharmacology*; D004286:Dolichols / Q000494:pharmacology*; D006888:Hydroxycholesterols / Q000494:pharmacology*; D007399:Interphase / Q000187:drug effects*; D007700:Kinetics; D008798:Mevalonic Acid / Q000494:pharmacology; D010982:Platelet-Derived Growth Factor / Q000494:pharmacology; D014451:Ubiquinone / Q000494:pharmacology*
D004224:Diterpenes; D004286:Dolichols; D006888:Hydroxycholesterols; D010982:Platelet-Derived Growth Factor; D014451:Ubiquinone; C007997:25-hydroxycholesterol; D002784:Cholesterol; D008798:Mevalonic Acid